Atrys Health SL risk profile
71 Stretched several inputs deteriorating together
Measured 21 October 2026 from ATRY's filed statements. Recomputed nightly.
71 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 49 | Elevated | Stable | One-year price volatility — 30.9% |
| Operating pressure | 59 | Elevated | Worsening | Costs outgrowing revenue — +9.7 percentage points |
| Cash conversion | 100 | Acute | Worsening | Capital spending against operating cash — -8.03x |
| Leverage and coverage | 97 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 66 | Stretched | Worsening | Revenue-growth gap against peers — -37.7 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.